STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11033-022-07399-w.pdf
Reference109 articles.
1. Kashyap D, Tuli HS, Yerer MB et al (2021) Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. Semin Cancer Biol 69:5–23. https://doi.org/10.1016/j.semcancer.2019.08.014
2. Valladares BT, Crespo PC, Herranz UA, Caamaño AG (2021) Adjuvant treatment in lung cancer. J Clin Transl Res 7:175–184. https://doi.org/10.18053/jctres.07.202102.012
3. Luna J, Sotoca A, Fernández P et al (2021) Recent advances in early stage lung cancer. J Clin Transl Res 7:163–174. https://doi.org/10.18053/jctres.07.202102.010
4. Lu X, Shi H, Que Q, Qiu S (2021) Research progress in immunotherapy of advanced non-small cell lung cancer. Trends Immunother 5:58–64
5. Furukawa F (2021) Effects of immune checkpoint inhibitors on cancer patients with preexisting autoimmune disease. Trends Immunother 5:5–6
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses;Cancer Research Communications;2024-02-01
2. PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC);Lung Cancer;2024-01
3. STAT3 gene polymorphisms and susceptibility to breast cancer in the Moroccan population;Egyptian Journal of Medical Human Genetics;2023-12-16
4. Lung cancer treatment potential and limits associated with the STAT family of transcription factors;Cellular Signalling;2023-09
5. Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance;Frontiers in Genetics;2023-01-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3